The pharmaceutical landscape for diabetes is changing, and transdermal GLP-1 delivery systems represent a potential advance. Unlike injections, this method offers a more convenient way to provide GLP-1 drugs. These https://deaconwoun426532.blog5star.com/41345154/glp-1-patches-a-novel-approach-to-diabetes-management